Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study

BACKGROUND. Vascular endothelial growth factor inhibitors have corticosteroid-sparing effects in patients with high-grade gliomas. We assessed corticosteroid use in patients with recurrent glioblastoma treated with bevacizumab (BEV) in the BRAIN study (J Clin Oncol 2009;27:4733–4740). METHODS. BRAIN...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Vredenburgh, James J., Cloughesy, Timothy, Samant, Meghna, Prados, Michael, Wen, Patrick Y., Mikkelsen, Tom, Schiff, David, Abrey, Lauren E., Yung, W.K. Alfred, Paleologos, Nina, Nicholas, Martin K., Jensen, Randy, Das, Asha, Friedman, Henry S.
Formato: Artigo
Idioma:Inglês
Publicado: AlphaMed Press 2010
Assuntos:
Neuro-Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227925/
https://ncbi.nlm.nih.gov/pubmed/21147867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0105
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares